亚太地区除颤器市场预测至 2028 年 - COVID-19 影响和区域分析(按产品(植入式心脏复律除颤器和体外除颤器)和最终用户(医院和诊所、院前护理、公共通道、家庭护理场所和替代护理设施)

Historic Data: 2019-2020   |   Base Year: 2021   |   Forecast Period: 2022-2028


No. of Pages: 139    |    Report Code: TIPRE00027800    |    Category: Life Sciences

Asia Pacific Defibrillator Market

市场介绍

亚太地区 (APAC) 是增长最快的区域市场除颤器;中国、印度、日本、韩国、澳大利亚和亚太地区其他地区是该地区市场的主要贡献者。由于国际企业在中国和印度的投资不断增加、各国政府支持的改善、CRO服务基础的扩大以及医疗基础设施的进步,亚太地区可能在2021年占据全球除颤器市场超过18.34%的市场份额。因此,该地区除颤器市场参与者在预测期内具有巨大的增长潜力。过去几年,中国医疗器械行业增长更快。推动中国医疗行业发展的因素包括持续的经济增长、中国“十三五”规划优先考虑健康和创新、对技术先进的医疗设备的需求增加、老年人口显着增加以及人们慢性病的增加。此外,低成本、熟练的劳动力以及巨大的生产空间吸引了各种市场领导者在中国设立生产工厂。人口资料局预计,到2050年,中国65岁及以上人口将达到3.66亿。世界卫生组织《中国老龄化与健康》报告显示,2019年,中国60岁及以上老年人中约75%患有心血管疾病、糖尿病、高血压等非传染性疾病。根据周等人2019年6月在《柳叶刀》上发表的报告,中国死亡率最高的四种疾病是脑卒中、缺血性心脏病、肺癌和慢性阻塞性肺病(COPD),明确表明心血管疾病对中国人的影响

COVID-19 大流行广泛影响了亚太地区的经济。供应链中断和对 COVID-19 患者有效治疗的巨大需求使该地区的医疗保健研究行业处于至关重要的境地。已采取禁止性措施来控制这一流行病的蔓延。 2020 年的一份新闻报道发现,在大流行期间,印度对除颤器的需求有所增加。随着心力衰竭成为危重 COVID-19 患者死亡的常见原因,全球和国内多家企业满足了对除颤器的需求。印度初创公司 Jeevtronics 将其产能从每月 60 台扩大到每月 200 台以上,以满足当地和全球的需求。此外,通过区域合作和捐赠,除颤器也被分发到各国,作为护理 COVID-19 患者的基本医疗设备。尽管该地区国家的大多数非必要手术都被搁置或推迟,但由于 COVID-19 患者的需求增加,对除颤器的需求保持不变。

市场概况和动态

亚太地区除颤器市场预计将从美元增长除颤器市场的增长。

关键细分市场

根据产品,市场分为植入式心律转复除颤器 (ICD) 和体外除颤器。 2020年,植入式心脏复律除颤器细分市场占据亚太除颤器市场最大份额。植入式心脏复律除颤器进一步细分为经静脉ICD和皮下ICD。经静脉 ICD 细分市场在 2020 年占据最大的市场份额。同样,体外细分市场又细分为手动、可穿戴和全自动体外除颤器。 2020年,手动细分市场占据最大市场份额。根据最终用户,亚太除颤器市场分为医院和诊所、院前护理、公共通道、家庭护理设施和替代护理设施。 2020年,医院和诊所细分市场占据最大份额。

主要来源和上市公司

准备本亚太地区除颤器市场报告时提到的一些主要一手和二手来源包括公司网站、年度报告、财务报告、国家政府文件、统计数据库等。报告中列出的主要公司有雅培(Abbott);百多力公司;波士顿科学公司; CU 医疗系统公司;皇家飞利浦公司;美敦力;日本光电公司;深圳迈瑞生物医疗电子有限公司;和 ZOLL MEDICAL CORPORATION 等

购买报告的理由

  • 了解亚太地区除颤器市场格局并确定最有可能保证丰厚回报的细分市场< /span>
  • 了解亚太除颤器市场不断变化的竞争格局,保持领先地位
  • 高效规划并购和并购合作伙伴关系通过确定最有前景的细分市场来开拓亚太除颤器市场
  • 通过对各种细分市场表现的敏锐而全面的分析,帮助做出明智的业务决策亚太除颤器市场
  • 获取亚太地区2021-2028年各细分市场的市场收入预测< /li>

亚太除颤器市场细分

< /span>

按产品

  • 植入式心脏复律除颤器< /span>
    • 经静脉 ICD
    • 皮下 ICD
  • < span>外部
    • 手动
    • 全自动体外除颤器
    • 可穿戴式

作者

< strong>最终用户

  • 医院和诊所
  • 院前护理
  • 公共服务
  • 替代护理设施
  • 家庭护理设置

按国家/地区

  • 澳大利亚
  • 中国
  • 印度
  • < li>日本
  • 韩国
  • 亚太其他地区
  • < /ul>

    公司简介

    • 雅培
    • Biotronik, Inc
    • 波士顿科学公司
    • CU Medical Systems, Inc.
    • Koninklijke Philips NV
    • 美敦力
    • 日本光电株式会社
    • 深圳市迈瑞生物医疗电子有限公司
    • ZOLL MEDICAL CORPORATION



    Asia Pacific Defibrillator Strategic Insights

    Strategic insights for Asia Pacific Defibrillator involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

    strategic-framework/asia-pacific-defibrillator-market-strategic-framework.webp
    Get more information on this report

    Asia Pacific Defibrillator Report Scope

    Report Attribute Details
    Market size in 2021 US$ 1,921.42 Million
    Market Size by 2028 US$ 2,865.30 Million
    Global CAGR (2021 - 2028) 5.9%
    Historical Data 2019-2020
    Forecast period 2022-2028
    Segments Covered By 产品
    • 植入式心脏复律除颤器及体外
    By 最终用户
    • 医院和诊所
    • 院前护理
    • 公共场所
    • 家庭护理机构
    • 替代护理机构
    Regions and Countries Covered 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 亚太其他地区
    Market leaders and key company profiles
  • Abbott
  • Biotronik, Inc
  • Boston Scientific Corporation
  • CU Medical Systems, Inc.
  • Koninklijke Philips N.V.
  • Medtronic
  • Nihon Kohden Corporation
  • Shenzhen Mindray Biomedical Electronics Co., Ltd
  • ZOLL MEDICAL CORPORATION
  • Get more information on this report

    Asia Pacific Defibrillator Regional Insights

    The regional scope of Asia Pacific Defibrillator refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/asia-pacific-defibrillator-market-geography.webp
    Get more information on this report

The List of Companies - Asia Pacific Defibrillator Market

  1. Abbott
  2. Biotronik, Inc
  3. Boston Scientific Corporation
  4. CU Medical Systems, Inc.
  5. Koninklijke Philips N.V.
  6. Medtronic
  7. Nihon Kohden Corporation
  8. Shenzhen Mindray Biomedical Electronics Co., Ltd
  9. ZOLL MEDICAL CORPORATION
Frequently Asked Questions
How big is the Asia Pacific Defibrillator Market?

The Asia Pacific Defibrillator Market is valued at US$ 1,921.42 Million in 2021, it is projected to reach US$ 2,865.30 Million by 2028.

What is the CAGR for Asia Pacific Defibrillator Market by (2021 - 2028)?

As per our report Asia Pacific Defibrillator Market, the market size is valued at US$ 1,921.42 Million in 2021, projecting it to reach US$ 2,865.30 Million by 2028. This translates to a CAGR of approximately 5.9% during the forecast period.

What segments are covered in this report?

The Asia Pacific Defibrillator Market report typically cover these key segments-

  • 产品 (植入式心脏复律除颤器及体外)
  • 最终用户 (医院和诊所, 院前护理, 公共场所, 家庭护理机构, 替代护理机构)
  • What is the historic period, base year, and forecast period taken for Asia Pacific Defibrillator Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Defibrillator Market report:

  • Historic Period : 2019-2020
  • Base Year : 2021
  • Forecast Period : 2022-2028
  • Who are the major players in Asia Pacific Defibrillator Market?

    The Asia Pacific Defibrillator Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Abbott
  • Biotronik, Inc
  • Boston Scientific Corporation
  • CU Medical Systems, Inc.
  • Koninklijke Philips N.V.
  • Medtronic
  • Nihon Kohden Corporation
  • Shenzhen Mindray Biomedical Electronics Co., Ltd
  • ZOLL MEDICAL CORPORATION
  • Who should buy this report?

    The Asia Pacific Defibrillator Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Defibrillator Market value chain can benefit from the information contained in a comprehensive market report.